//
Lilly Cares Foundation Inc. is a private corporation based in INDIANAPOLIS, IN. The foundation received its IRS ruling in 1998. The principal officer is % Irma Tragesser. It holds total assets of $1. Annual income is reported at $4.1B. THE FOUNDATION CONDUCTED ACTIVITIES DESCRIBED IN CODE SECTION 170(C)(2)(B) BY DISTRIBUTING MEDICINES, PRESCRIPTION DRUGS, AND OTHER PHARMACEUTICAL PRODUCTS AND MEDICAL SUPPLIES (PHARMACEUTICAL PRODUCTS), DONATED TO IT BY ELI LILLY AND COMPANY (DONOR) TO THE ILL, NEEDY, AND INFANTS WHO MET THE FOUNDATION'S ELIGIBILITY REQUIREMENTS (ELIGIBLE PATIENTS). THE PHARMACEUTICAL PRODUCTS IT RECEIVED FROM THE DONOR WERE DISTRIBUTED FOR CHARITABLE PURPOSES AND AT NO CHARGE, FOR THE CARE OF ELIGIBLE PATIENTS. DURING 2023, THE FOUNDATION DISTRIBUTED OVER $4 BILLION OF PRODUCTS TO OVER 197,000 ELIGIBLE PATIENTS FOR DIABETES, IMMUNE DISORDERS, CANCER, WOMEN'S, MEN'S AND CHILDREN'S HEALTH, MENTAL HEALTH, AND PAIN. Contributions to this foundation are tax-deductible.
THE FOUNDATION CONDUCTED ACTIVITIES DESCRIBED IN CODE SECTION 170(C)(2)(B) BY DISTRIBUTING MEDICINES, PRESCRIPTION DRUGS, AND OTHER PHARMACEUTICAL PRODUCTS AND MEDICAL SUPPLIES (PHARMACEUTICAL PRODUCTS), DONATED TO IT BY ELI LILLY AND COMPANY (DONOR) TO THE ILL, NEEDY, AND INFANTS WHO MET THE FOUNDATION'S ELIGIBILITY REQUIREMENTS (ELIGIBLE PATIENTS). THE PHARMACEUTICAL PRODUCTS IT RECEIVED FROM THE DONOR WERE DISTRIBUTED FOR CHARITABLE PURPOSES AND AT NO CHARGE, FOR THE CARE OF ELIGIBLE PATIENTS. DURING 2023, THE FOUNDATION DISTRIBUTED OVER $4 BILLION OF PRODUCTS TO OVER 197,000 ELIGIBLE PATIENTS FOR DIABETES, IMMUNE DISORDERS, CANCER, WOMEN'S, MEN'S AND CHILDREN'S HEALTH, MENTAL HEALTH, AND PAIN.
Expenses: $4.2B
THE FOUNDATION CONDUCTED ACTIVITIES DESCRIBED IN CODE SECTION 170(C)(2)(B) BY DISTRIBUTING MEDICINES, PRESCRIPTION DRUGS, AND OTHER PHARMACEUTICAL PRODUCTS AND MEDICAL SUPPLIES (PHARMACEUTICAL PRODUCTS), DONATED TO IT BY ELI LILLY AND COMPANY (DONOR) TO THE ILL, NEEDY, AND INFANTS WHO MET THE FOUNDATION'S ELIGIBILITY REQUIREMENTS (ELIGIBLE PATIENTS). THE PHARMACEUTICAL PRODUCTS IT RECEIVED FROM THE DONOR WERE DISTRIBUTED FOR CHARITABLE PURPOSES AND AT NO CHARGE, FOR THE CARE OF ELIGIBLE PATIENTS. DURING 2023, THE FOUNDATION DISTRIBUTED OVER $4 BILLION OF PRODUCTS TO OVER 197,000 ELIGIBLE PATIENTS FOR DIABETES, IMMUNE DISORDERS, CANCER, WOMEN'S, MEN'S AND CHILDREN'S HEALTH, MENTAL HEALTH, AND PAIN.
PHARMACEUTICALS ARE DISTRIBUTED TO THE ILL, NEEDY, THE INDIGENT, AND INFANTS BASED ON MULTIPLE OF THE FEDERAL POVERTY LEVEL. IN ADDITION, CRITERIA INCLUDES US RESIDENCY STATUS, A LICENSED HCP PRESCRIBING AN ELI LILLY & COMPANY MEDICATION, AND INSURANCE STATUS.
Lilly Cares Foundation Inc. is headquartered in INDIANAPOLIS, IN.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Erin Conway | ASSISTANT SECRETARY (END 2/22) | $0 | $0 | $0 |
| Jonathan Groff | secretary | $0 | $0 | $0 |
| Steven Stapleton | VP (end 3/22) | $0 | $0 | $0 |
| Sherry Davis | DIRECTOR | $0 | $0 | $0 |
| Elias Khalil | DIRECTOR (End 04/22) | $0 | $0 | $0 |
Total Giving
$4.2B
Total Assets
$1
Fair Market Value
$0
Net Worth
$1
Grants Paid
$0
Contributions
$4.1B
Net Investment Income
$0
Distribution Amount
$0
SUPERIOR, CO
NEW BRUNSWICK, NJ
MORRISTOWN, NJ
RED BANK, NJ
| Jack R Goodpasture |
| Director,BOARD CHAIR(BEG 4/22) |
| $0 |
| $0 |
| $0 |
| Michael Hulka | DIRECTOR | $0 | $0 | $0 |
| Irma Tragesser | President | $0 | $0 | $0 |
| Philip Johnson | TREASURER | $0 | $0 | $0 |
| Chris Anderson | ASSISTANT SECRETARY(beg 04/22) | $0 | $0 | $0 |
| Weikai C Fang | Director, CM of Bd (End 4/22) | $0 | $0 | $0 |
© 2026 Granted AI